Diabetes, Obstructive sleep apnea
Conditions
Interventions
Outpatient group:Patients who are positive for OSAS questionnaire screening and who are positive for home sleep monitoring (HST) are encouraged to go to an OSAS specialist or tertiary hospital for dia
Control group:Patients who tested positive for OSAS were mobilized to go to OSAS specialist or tertiary hospitals for OSAS diagnosis and treatment
Integrated management group:Patients who were positive for OSAS questionnaire screening and who were positive for sleep monitoring at home (HST) were treated with remote diagnosis, CPAP treatment and
Sponsors
Institute for Chronic Non-communicable Disease Control and Prevention, Hangzhou Center for Disease Control and Prevention (Hangzhou Health Supervision Institution)
Eligibility
Sex/Gender
All
Age
25 Years to 69 Years
Inclusion criteria
Inclusion criteria: (1) Age 25-69 years old; (2) Overweight or obesity (body mass index BMI is 25Kg/m^2); (3) PRIOR DIAGNOSIS OF TYPE 2 DIABETES MELLITUS, DEFINED AS: [I] CURRENT ORAL ANTIDIABETIC MEDICATIONS AND/OR INSULIN; or [II] at least 2 fasting blood glucose levels >126mg/dL; or [III] 2 hours later, oral glucose tolerance test: blood glucose level>=200mg/dL; or [IV.] glycosylated hemoglobin (HbA1c) >6.5%; (4) The diabetes medication was stable in the past 4 weeks, and the healthy lifestyle behavior did not change greatly; (5) Resident at the selected study site (selected street/township) and belong to the diabetes patient under management; (6) Can access the Internet and make and receive calls, fluent in Chinese; (7) Sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Have any kind of diabetic complications (nephropathy, neuropathy, retinopathy, diabetic foot); (2) severe daytime sleepiness (Epworth sleep score >18); (3) Acute coronary syndrome, stroke, transient ischemic attack, or hospitalization due to worsening heart failure within the previous 30 days; (4) other types of diabetes other than type 2 diabetes; (5) Systolic blood pressure >= 180mmHg or diastolic blood pressure >= 110mmHg; (6) continuous treatment with non-steroidal anti-inflammatory drugs, or regular use of sleep-improving psychotropic drugs; (7) Prior CPAP therapy; (8) Known renal insufficiency, creatinine concentration greater than 1.5mg/dl; (9) Patients engaged in hazardous occupations or work involving dangerous goods; (10) Women of childbearing potential who are pregnant or do not have contraception.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c;Homeostatic Model Assessment of Insulin Resistance;Usage of hypoglycemic agents; | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional Outcomes of Sleep Questionnaire - 10, FOSQ-10;Diagnosis rate of OSAS;Treatment rate of OSAS ;The average daily usage time of CPAP (Continuous Positive Airway Pressure) device; | — |
Countries
China
Contacts
Public ContactJue Xu
Hangzhou Center for Disease Control and Prevention (Hangzhou Health Supervision Institution)
Outcome results
None listed